BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $328,794 | -39.3% | 7,505 | -8.8% | 0.00% | -50.0% |
| Q3 2022 | $542,000 | +30.6% | 8,227 | +0.2% | 0.01% | +33.3% |
| Q2 2022 | $415,000 | -21.0% | 8,210 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $525,000 | -40.3% | 8,210 | -0.1% | 0.01% | -50.0% |
| Q4 2021 | $880,000 | +4.3% | 8,219 | +0.1% | 0.01% | +27.3% |
| Q3 2021 | $844,000 | +3.2% | 8,212 | -11.7% | 0.01% | +10.0% |
| Q2 2021 | $818,000 | -2.0% | 9,300 | +8.3% | 0.01% | -16.7% |
| Q1 2021 | $835,000 | -0.7% | 8,589 | +14.5% | 0.01% | 0.0% |
| Q4 2020 | $841,000 | +21.0% | 7,500 | 0.0% | 0.01% | +9.1% |
| Q3 2020 | $695,000 | – | 7,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |